Functional status ‐ 6MWD (metres) · COPD and at least one other long‐term condition
1 finding from 1 review
Hospital admissions · COPD and at least one other long‐term condition
Intervention showed no clear difference in all‐cause hospital admissions ‐ people experiencing one or more  compared with usual care (low certainty).
1 finding from 1 review
All‐cause mortality (deaths) Â · COPD and at least one other long‐term condition
It is very uncertain whether intervention changes all‐cause mortality (deaths) Â compared with usual care (very low certainty).
1 finding from 1 review
Outcome domain · COPD and at least one other long‐term condition
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
SGRQ Total SGRQ (Total) Score. Scale from: 0 to 100. Lower score indicates better quality of life. · COPD and at least one other long‐term condition
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Visual acuity · infantile nystagmus syndrome
1 finding from 1 review
Change in head posture ‐ not reported · infantile nystagmus syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in intensity of the nystagmus waveform · infantile nystagmus syndrome
1 finding from 1 review
Change in foveation period durations of the waveform ‐ not reported · infantile nystagmus syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in visual recognition times ‐ not reported · infantile nystagmus syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in proportion of participants with adverse effects with a probable causal link to the treatment · infantile nystagmus syndrome
1 finding from 1 review
Change in quality of life · infantile nystagmus syndrome
1 finding from 1 review
Vertebral fracture by radiography · postmenopausal women with osteoporosis and CKD stages 3‐4
Any anti‐osteoporotic drugs may leads to lower vertebral fracture by radiography compared with placebo (low certainty).
1 finding from 1 review
Vertebral fracture by radiography · postmenopausal women with osteoporosis and CKD stages 5 and 5D
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical fracture · postmenopausal women with osteoporosis and CKD stages 5 and 5D
It is very uncertain whether raloxifene changes clinical fracture compared with placebo (very low certainty).
1 finding from 1 review
Mean change in BMD of the femoral neck · postmenopausal women with osteoporosis and CKD stages 5 and 5D
It is very uncertain whether raloxifene changes mean change in BMD of the femoral neck compared with placebo (very low certainty).
1 finding from 1 review
Mean change in BMD of the lumbar spine · postmenopausal women with osteoporosis and CKD stages 5 and 5D
Raloxifene may leads to higher mean change in BMD of the lumbar spine compared with placebo (low certainty).
1 finding from 1 review
Total hip BMD · postmenopausal women with osteoporosis and CKD stages 5 and 5D
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean change in BMD of the distal radius · postmenopausal women with osteoporosis and CKD stages 5 and 5D
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · postmenopausal women with osteoporosis and CKD stages 5 and 5D
1 finding from 1 review